Here are four observations:
1. Mr. Lieber has more than 20 years of executive management experience at emerging life sciences companies and in investment banking.
2. Mr. Lieber most recently served as the CFO of Metamark Genetics, a privately held, urology-focused, molecular diagnostics company.
3. He has also served as the CFO and treasurer of Repligen Corporation and CFO of Xcellerex.
4. Histogenics is a regenerative medicine company focused on developing and marketing products in the musculoskeletal marketplace.
More articles on devices:
Michael Turpin joins K2M board of directors — 5 key notes
22 things to know about Stryker
FDA grants Centinel Spine allogeneic bone graft indications for lumbar spinal fusion line — 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
